• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Single cancer cell 'poses danger'

AlaskaDenise

In Memoriam
Cancer researchers may have underestimated the power of some cancers to spread and cause new tumours, say US researchers.

They found just one skin cancer cell was often enough to generate a whole new tumour.

The finding, published in the journal Nature, undermines hopes that only certain types of cancer cell could fuel the spread of the disease.

UK experts said more work was needed to pinpoint exactly how cancer cells work.



The cancer studied by the team from the Howard Hughes Medical Institute and the University of Michigan was melanoma, well known for its ability to spread lethally from a single site.

Normally the ability of a single cell to "seed" a new tumour is tested by injecting large quantities into mice with weakened immune systems and counting how many tumours emerge.

The relatively small proportion of tumours supported the view of many scientists that not all cancer cells could trigger a new tumour, and that this ability was confined to a smaller number of specialist "cancer stem cells".

However, Dr Sean Morrison, who led the latest work, said that this approach was flawed because the mice still had some immunity to these human cancer cells, leading to a significant underestimation of their potency.

One in four

First his team injected melanoma cells into mice with even more severely weakened immune systems, and found that 250,000 times as many of them formed tumours.

When single melanoma cells were used, they discovered that roughly one in four of them went on to seed new tumours.

He said: "As far as we know, this is the first time anyone has been able to show that individual cells from human cancers can efficiently form tumours."

For this reason, identifying and targeting a small subset of these cells just would not work, he said.

"We think the underestimation of tumour-causing cells is a general problem in many cancers, not just specific to melanoma."

He said that researchers needed to make their tests better to see if their cancers were equally potent.

In addition, his team used a battery of tests, but could find nothing marking out any of the cells as potential "cancer stem cells".

While this did not disprove their existence, he said, it could mean that some cancers, such as melanomas, were "good old-fashioned cancer", in which every cell was dangerous.

A spokesman for Cancer Research UK, Ed Yong, said that the idea that tumours grew from a tiny number of "cancer stem cells" was one of the "most interesting" in current research.

"But this study suggests that it may not be true for every type of cancer - in melanoma, a much larger proportion of cancer cells are able to give rise to a new tumour.
"It shows how important it is that we continue to fund research into how cancers develop at a fundamental level."


Story from BBC NEWS:
http://news.bbc.co.uk/go/pr/fr/-/2/hi/health/7762474.stm
 
Re: Single cancer cell 'poses danger'

#1: ""It shows how important it is that we continue to fund research into how cancers develop at a fundamental level.""


And how important it is at the same time to finaly cut off the worldwide environmental toxic sources which in many cases stimulate the insurgence of this deadly group of illness worldwide ...
 
Re: Single cancer cell 'poses danger'

I read my medical daily newspaper and I find an article identical:

Cancer : la th?orie de la cellule souche remise en cause
Selon la th?orie de la cellule souche canc?reuse, seules de tr?s rares cellules pr?sentes dans une tumeur (de 0,1 ? 0,0001 %) sont capables de former une nouvelle tumeur. Telles ?taient les conclusions d'?tudes men?es chez des souris immunod?ficientes NOD/SCI, capables de rejeter les cellules tumorales transf?r?es. Mais ces souris dites immunod?ficientes poss?dent tout de m?me des lymphocytes NK. Ce qui a conduit l'?quipe de Morisson ? s'int?resser ? des souris r?ellement immunod?ficientes. D?s lors, en travaillant dans le mod?le du m?lanome, les chercheurs ont d?couvert qu'environ un quart des cellules tumorales est capable de former une nouvelle tumeur. Observation qui pourrait ?tre valable dans d'autres cancers, mais probablement pas tous, selon les chercheurs.

> Dr E. V.

? Nature ?, p.593

Quotimed.com, le 04/12/2008


http://www.quotimed.com/flashs/index.cfm?FUSEACTION=viewflashinfo&FLASHIDX=12743&


Traduction machine

Cancer: the theory of the original cell called into question According to the theory of the cancerous original cell, only of very rare cells present in a tumour (from 0,1 to 0,0001%) are able to form a new tumour. Such were the d' conclusions; studies undertaken in mice immunod?ficientes NOD/SCI, able to reject the transferred tumoral cells. But these mice known as immunod?ficientes have lymphocytes NK all the same. What led l' equip with Morisson with s' to interest in mice really immunod?ficientes. Consequently, while working in the model of the melanomist, the researchers discovered qu' approximately a quarter of the tumoral cells is able to form a new tumour. Observation which could be valid in d' other cancers, but probably not all, according to the researchers.

L'article de NATURE


Nature 456, 593-598 (4 December 2008) | <abbr title="Digital Object Identifier">doi</abbr>:10.1038/nature07567; Received 21 August 2008; Accepted 14 October 2008
Efficient tumour formation by single human melanoma cells

Elsa Quintana<sup>1,</sup><sup>3</sup>, Mark Shackleton<sup>1,</sup><sup>3</sup>, Michael S. Sabel, Douglas R. Fullen, Timothy M. Johnson<sup>4</sup> & Sean J. Morrison<sup>1</sup>

  1. Howard Hughes Medical Institute, Life Sciences Institute, Department of Internal Medicine, and Center for Stem Cell Biology, University of Michigan, Ann Arbor, Michigan 48109-2216, USA
  2. Department of Dermatology, University of Michigan, Ann Arbor, Michigan 48109, USA
  3. These authors contributed equally to this work.
Correspondence to: Sean J. Morrison<sup>1</sup> Correspondence and requests for materials should be addressed to S.J.M. (Email: seanjm@umich.edu).

Top of pageAbstract

A fundamental question in cancer biology is whether cells with tumorigenic potential are common or rare within human cancers. Studies on diverse cancers, including melanoma, have indicated that only rare human cancer cells (0.1?0.0001%) form tumours when transplanted into non-obese diabetic/severe combined immunodeficiency (NOD/SCID) mice. However, the extent to which NOD/SCID mice underestimate the frequency of tumorigenic human cancer cells has been uncertain. Here we show that modified xenotransplantation assay conditions, including the use of more highly immunocompromised NOD/SCID interleukin-2 receptor gamma chain null (Il2rg<sup>-/-</sup>) mice, can increase the detection of tumorigenic melanoma cells by several orders of magnitude. In limiting dilution assays, approximately 25% of unselected melanoma cells from 12 different patients, including cells from primary and metastatic melanomas obtained directly from patients, formed tumours under these more permissive conditions. In single-cell transplants, an average of 27% of unselected melanoma cells from four different patients formed tumours. Modifications to xenotransplantation assays can therefore dramatically increase the detectable frequency of tumorigenic cells, demonstrating that they are common in some human cancers.


  1. Howard Hughes Medical Institute, Life Sciences Institute, Department of Internal Medicine, and Center for Stem Cell Biology, University of Michigan, Ann Arbor, Michigan 48109-2216, USA
  2. Department of Dermatology, University of Michigan, Ann Arbor, Michigan 48109, USA
  3. These authors contributed equally to this work.
 
Re: Single cancer cell 'poses danger'

One cell may be able to grow into serious cancer, but they don't report that a healthy immune system can kill off defective cells. That's part of the function of our P53 gene - order defective cells to commit apoptosis and not reproduce.

So part of those research goals should be to define what it takes for the immune system to maintain it's ability to effectively fight off cancer. This information is not well publicized.

But, alas, there are no private enterprise profits in prevention :(

.
 
Re: Single cancer cell 'poses danger'

"a healthy immune system can kill off defective cells"

I agree.
But, a healthy one.

As you said, no or little prevention, especialy in upgrading new, more stringent, env./food/water/air healthier safety standards.

How many pc. of humans today realy have a healthy immune system?

And if they have it, how long it will take in today's world to became corrupted?

From FT:
http://www.flutrackers.com/forum/showthread.php?t=87100
toxicals into us and infection - "Dr Whiting on CNN Planets in Peril"

"The immune system is also being compromised by this constant toxic overload. We can see this in the form of new super bugs and highly resistant staph infections. These super bugs and new strains of staph infections are now often fatal because the immune system of many of us has been so severely damaged by chronic toxic poisoning"
 
Back
Top Bottom